Request for Covid-19 Impact Assessment of this Report

Materials and Chemicals

United States Naproxen Market Report 2016

  • QYR808351
  • 99 Pages
  • December 2016
  • Materials and Chemicals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Naproxen

Revenue, means the sales value of Naproxen

This report studies sales (consumption) of Naproxen in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Teva

Kirsch Pharma GmbH

Aurobindo

Divis Laboratories

Taj Pharmaceuticals Limited

Tianxin Pharmaceutical

Charioteer Pharmaceutical

Nhwa Pharmaceutical

Huazhong Pharma

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Naproxen in each application, can be divided into

Tablet

Capsule

Other

Table of Contents

United States Naproxen Market Report 2016

1 Naproxen Overview

1.1 Product Overview and Scope of Naproxen

1.2 Classification of Naproxen

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Naproxen

1.3.1 Tablet

1.3.2 Capsule

1.3.3 Other

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Naproxen (2011-2021)

1.4.1 United States Naproxen Sales and Growth Rate (2011-2021)

1.4.2 United States Naproxen Revenue and Growth Rate (2011-2021)

2 United States Naproxen Competition by Manufacturers

2.1 United States Naproxen Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Naproxen Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Naproxen Average Price by Manufactures (2015 and 2016)

2.4 Naproxen Market Competitive Situation and Trends

2.4.1 Naproxen Market Concentration Rate

2.4.2 Naproxen Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Naproxen Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Naproxen Sales and Market Share by Type (2011-2016)

3.2 United States Naproxen Revenue and Market Share by Type (2011-2016)

3.3 United States Naproxen Price by Type (2011-2016)

3.4 United States Naproxen Sales Growth Rate by Type (2011-2016)

4 United States Naproxen Sales (Volume) by Application (2011-2016)

4.1 United States Naproxen Sales and Market Share by Application (2011-2016)

4.2 United States Naproxen Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Naproxen Manufacturers Profiles/Analysis

5.1 Teva

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Naproxen Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Teva Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Kirsch Pharma GmbH

5.2.2 Naproxen Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Kirsch Pharma GmbH Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Aurobindo

5.3.2 Naproxen Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Aurobindo Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Divis Laboratories

5.4.2 Naproxen Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Divis Laboratories Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Taj Pharmaceuticals Limited

5.5.2 Naproxen Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Taj Pharmaceuticals Limited Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Tianxin Pharmaceutical

5.6.2 Naproxen Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Tianxin Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Charioteer Pharmaceutical

5.7.2 Naproxen Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Charioteer Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Nhwa Pharmaceutical

5.8.2 Naproxen Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Nhwa Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Huazhong Pharma

5.9.2 Naproxen Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Huazhong Pharma Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

6 Naproxen Manufacturing Cost Analysis

6.1 Naproxen Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Naproxen

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Naproxen Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Naproxen Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Naproxen Market Forecast (2016-2021)

10.1 United States Naproxen Sales, Revenue Forecast (2016-2021)

10.2 United States Naproxen Sales Forecast by Type (2016-2021)

10.3 United States Naproxen Sales Forecast by Application (2016-2021)

10.4 Naproxen Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Naproxen

Table Classification of Naproxen

Figure United States Sales Market Share of Naproxen by Type in 2015

Table Application of Naproxen

Figure United States Sales Market Share of Naproxen by Application in 2015

Figure Tablet Examples

Figure Capsule Examples

Figure Other Examples

Figure United States Naproxen Sales and Growth Rate (2011-2021)

Figure United States Naproxen Revenue and Growth Rate (2011-2021)

Table United States Naproxen Sales of Key Manufacturers (2015 and 2016)

Table United States Naproxen Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Naproxen Sales Share by Manufacturers

Figure 2016 Naproxen Sales Share by Manufacturers

Table United States Naproxen Revenue by Manufacturers (2015 and 2016)

Table United States Naproxen Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Naproxen Revenue Share by Manufacturers

Table 2016 United States Naproxen Revenue Share by Manufacturers

Table United States Market Naproxen Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Naproxen Average Price of Key Manufacturers in 2015

Figure Naproxen Market Share of Top 3 Manufacturers

Figure Naproxen Market Share of Top 5 Manufacturers

Table United States Naproxen Sales by Type (2011-2016)

Table United States Naproxen Sales Share by Type (2011-2016)

Figure United States Naproxen Sales Market Share by Type in 2015

Table United States Naproxen Revenue and Market Share by Type (2011-2016)

Table United States Naproxen Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Naproxen by Type (2011-2016)

Table United States Naproxen Price by Type (2011-2016)

Figure United States Naproxen Sales Growth Rate by Type (2011-2016)

Table United States Naproxen Sales by Application (2011-2016)

Table United States Naproxen Sales Market Share by Application (2011-2016)

Figure United States Naproxen Sales Market Share by Application in 2015

Table United States Naproxen Sales Growth Rate by Application (2011-2016)

Figure United States Naproxen Sales Growth Rate by Application (2011-2016)

Table Teva Basic Information List

Table Teva Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Teva Naproxen Sales Market Share (2011-2016)

Table Kirsch Pharma GmbH Basic Information List

Table Kirsch Pharma GmbH Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Kirsch Pharma GmbH Naproxen Sales Market Share (2011-2016)

Table Aurobindo Basic Information List

Table Aurobindo Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Aurobindo Naproxen Sales Market Share (2011-2016)

Table Divis Laboratories Basic Information List

Table Divis Laboratories Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Divis Laboratories Naproxen Sales Market Share (2011-2016)

Table Taj Pharmaceuticals Limited Basic Information List

Table Taj Pharmaceuticals Limited Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Taj Pharmaceuticals Limited Naproxen Sales Market Share (2011-2016)

Table Tianxin Pharmaceutical Basic Information List

Table Tianxin Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Tianxin Pharmaceutical Naproxen Sales Market Share (2011-2016)

Table Charioteer Pharmaceutical Basic Information List

Table Charioteer Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Charioteer Pharmaceutical Naproxen Sales Market Share (2011-2016)

Table Nhwa Pharmaceutical Basic Information List

Table Nhwa Pharmaceutical Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nhwa Pharmaceutical Naproxen Sales Market Share (2011-2016)

Table Huazhong Pharma Basic Information List

Table Huazhong Pharma Naproxen Sales, Revenue, Price and Gross Margin (2011-2016)

Table Huazhong Pharma Naproxen Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Naproxen

Figure Manufacturing Process Analysis of Naproxen

Figure Naproxen Industrial Chain Analysis

Table Raw Materials Sources of Naproxen Major Manufacturers in 2015

Table Major Buyers of Naproxen

Table Distributors/Traders List

Figure United States Naproxen Production and Growth Rate Forecast (2016-2021)

Figure United States Naproxen Revenue and Growth Rate Forecast (2016-2021)

Table United States Naproxen Production Forecast by Type (2016-2021)

Table United States Naproxen Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Global Photonic Crystals Market (Construction Strategies, Geography , Applications) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.

  • Publish Date: February 8, 2017
  • $5370
Molded Plastics Market by Product (Polyvinyl Chloride, Polypropylene, Polystyrene, Low Density Polyethylene, High Density Polyethylene, Polyethylene Terephthalate, and Engineering Plastics), Technology (Injection Molding, Blow Molding, Extrusion, and Others), and Application (Building & Construction, Electrical & Electronics, Automotive and Packaging) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...

  • Publish Date: July 4, 2017
  • $5370